Co-Founder @ Presagen
Michelle has a PhD in Medicine and was a stem cell biologist for a decade. She founded her first AI business 10 years ago which was acquired by Ernst and Young in 2015. She is now co-founder and CEO of Presagen which is an AI company that specializes in creating globally scalable image-based medical diagnostics products, using its advanced AI platform. Presagen’s first product is Life Whisperer that uses AI to assist clinicians to select viable embryos in IVF to improve outcomes for couples wanting to have children. Michelle is also a dedicated mentor and advisory board member for many startups, and an Advisory Board Member to the University of South Australia Business School.